AlphaSense

👀 Market intelligence just got a major upgrade. Multi-step research and monitoring workflows, conducted on your behalf. Introducing SuperAnalyst, an always-on AI agent that doesn't just answer questions, it executes the work. This isn't another chatbot. SuperAnalyst builds custom dashboards, tracks developments, synthesizes new information, and surfaces actionable insights as situations evolve, all grounded in premium, trusted content. This means no daily queries and less hunting and gathering to understand market intelligence in your segment. Now, you can execute complex, high-stakes workflows at scale. Learn more here: https://lnkd.in/eD7kHzbW

The IPO market is showing real signs of life, with a slate of mega-cap candidates from AI to space setting the stage for a more active listing environment. We break down what's fueling the shift, and dig into key sector debates around cloud data platforms as AI infrastructure beneficiaries, Doximity's clinical AI bet, and the NextEra-Dominion mega-merger. Your go-to source for expert insights into the forces shaping today's markets, delivered twice a month. Read and subscribe today ⤵️

Your AI doesn't flag a weak expert transcript: it treats it with the same authority as every other signal in your library. If your library was built on generic sourcing, static expert pools, or incomplete compliance, every query you run is compounding that problem at scale. The real differences show up in who commissioned the calls, how experts were sourced, and whether compliance extends to every single transcript your LLM is permitted to retrieve. Does your expert transcript library actually check every box that matters? Run through our checklist and read more here: https://lnkd.in/eFcuEaYf

What does market conviction look like? A $350M raise at a $7.5B valuation. Today, we have closed that $350M round and nearly doubled our valuation, all backed by Vitruvian Partners, Accenture Ventures, J.P. Morgan Asset Management, The D. E. Shaw Group, Pinegrove Opportunity Partners, and our returning investors CapitalG, Goldman Sachs Asset Management, and Viking Global Investors. Doubling down on their investment, we have also established a new channel partnership with Accenture to further fuel organizations embedding and scaling market intelligence into their core agentic workflows. The era of fragmented tools in market intelligence has given way to a more integrated approach with the advent of AI and that's why we are also announcing the launch of SuperAnalyst. AI prompts and queries are the workflow most analysts know today but now multi-step research and monitoring tasks can be automated on the user's behalf. These announcements are more than just momentous milestones: they are an inflection point for the future of market intelligence. We couldn't be more excited to keep building it. https://lnkd.in/eC4TYdTu

🏆 Four years in a row. AlphaSense has been named to Inc. Magazine's 2026 Best Workplaces list, a testament to the team, culture, and mission driving everything we do. As we continue to grow globally and push the boundaries of AI, we remain committed to building a workplace where people thrive. Thank you to our incredible team for making AlphaSense a place where the work truly matters! https://lnkd.in/eEBdPaEu

Geopolitical tensions have revealed vulnerabilities in several Asia-Pacific economies with disruptive factors active in every market. For corporate leaders and investors, translating these divergent macro dynamics into sector-level strategy is the difference between getting ahead of disruption and being caught off guard by it. We break down the key forces shaping the APAC macro environment in 2026, with implications for business leaders and investors across the region. Read the full report here: https://lnkd.in/evASAWKt

Slashing your research time from 5 days down to just 5 minutes? Yes, it's possible: just ask Diana Gowe of Johnson & Johnson. The Director of Global Commercial Strategy recently walked through her competitive intelligence workflow on AlphaSense by comparing pipeline developments across AbbVie, Pfizer, Merck, and Bristol Myers Squibb in a single query. Every insight sourced. Every source clickable. This is what AI-native CI looks like in practice, not just faster research, but a fundamentally different way to move from raw market signals to executive-ready strategy. Watch the full webinar: https://lnkd.in/g9J6Khvv